معرفی
Samuel Sathyanesan is Professor of Basic Biomedical Sciences at the University of South Dakota, where he leads the Molecular Neuropsychiatry Laboratory. His research investigates multifunctional trophic factors in CNS disorders, focusing on neuropsychiatric diseases, blood-brain barrier mechanisms, and trophic signaling pathways to develop novel therapeutics for mood disorders.
His educational background includes dual PhDs:
- PhD in Molecular Physiology, University of Notre Dame (2000)
- PhD in Biotechnology, University of Madras (1995)
Dr. Sathyanesan's work centers on neurovascular biology and trophic factor signaling, examining how molecules like erythropoietin derivatives influence neuronal-vascular health in depression and cognitive deficits. His lab employs omics technologies, transgenic models, and computational structural biology to dissect mechanisms of antidepressant action.
Recent publications reveal a strong trend toward non-erythropoietic EPO derivatives (e.g., carbamoylated EPO) for treating anxiety/depression, alongside investigations into orexin receptor modulation and psychedelic compounds. His work consistently bridges molecular neuroscience with translational applications.
Scientific recognition includes:
- NARSAD Young Investigator Award (2003)
He has secured substantial NIH funding for projects including 'Characterization of trophic factor induced antidepressant action' (RO1 MH106640) and 'Cardiac sympathetic afferent reflex control.' Dr. Sathyanesan mentors graduate students like Morgan Rothschadl and collaborates with Yale consultants Prof. Marina Picciotto and Prof. Ralph Dileone on molecular psychiatry initiatives.
The Molecular Neuropsychiatry Laboratory operates from Lee Medicine & Science Hall, integrating gene expression analysis, structural biology, and animal behavior studies. Current projects include nanoparticle-assisted brain delivery of neurotrophic factors and computational design of therapeutic peptides targeting late-onset Alzheimer's disease.
